General Court confirms likelihood of confusion between PRIMART and PRIMA

General Court confirms likelihood of confusion between PRIMART and PRIMA European Union – Grau & Angulo EUIPO Board of Appeal found likelihood of confusion between PRIMART and PRIMA in Class 30 Court con rmed that signs were visually similar to an average degree, and phonetically similar to an higher-than-average degree Group of letters ‘prima’ contributed…

Detalles

Barcelona patent court upholds valsartan-amlodipine patent invalidity

On 14 March 2018 the Barcelona Commercial Court Number 4 dismissed a patent infringement action brought by Novartis against the first generics in Spain of its valsartan and amlodipine medicinal product for the treatment of hypertension (Exforge). The court upheld the defendants’ counterclaim for invalidity of the asserted patent.

Detalles